Acorah Software Products - Accounts Production 15.0.600 false true 30 November 2022 1 December 2021 false 1 December 2022 30 November 2023 30 November 2023 12293966 Mr Simon Bate Dr Edward Good Mr Philip Hodari iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12293966 2022-11-30 12293966 2023-11-30 12293966 2022-12-01 2023-11-30 12293966 frs-core:CurrentFinancialInstruments 2023-11-30 12293966 frs-core:ShareCapital 2023-11-30 12293966 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30 12293966 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12293966 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 12293966 frs-bus:SmallEntities 2022-12-01 2023-11-30 12293966 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 12293966 frs-bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 12293966 frs-bus:Director1 2022-12-01 2023-11-30 12293966 frs-bus:Director2 2022-12-01 2023-11-30 12293966 frs-bus:CompanySecretary1 2022-12-01 2023-11-30 12293966 frs-countries:EnglandWales 2022-12-01 2023-11-30 12293966 2021-11-30 12293966 2022-11-30 12293966 2021-12-01 2022-11-30 12293966 frs-core:CurrentFinancialInstruments 2022-11-30 12293966 frs-core:ShareCapital 2022-11-30 12293966 frs-core:RetainedEarningsAccumulatedLosses 2022-11-30
Registered number: 12293966
Tecrea Animal Health Limited
Unaudited Financial Statements
For The Year Ended 30 November 2023
Integral Finance Limited
BioHub at Alderley Park
Alderley Park
Alderley Edge
SK10 4TG
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 12293966
2023 2022
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 57,568 57,568
57,568 57,568
Creditors: Amounts Falling Due Within One Year 5 (40,998 ) (40,998 )
NET CURRENT ASSETS (LIABILITIES) 16,570 16,570
TOTAL ASSETS LESS CURRENT LIABILITIES 16,570 16,570
NET ASSETS 16,570 16,570
CAPITAL AND RESERVES
Called up share capital 6 1 1
Profit and Loss Account 16,569 16,569
SHAREHOLDERS' FUNDS 16,570 16,570
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Simon Bate
Director
30 August 2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Tecrea Animal Health Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12293966 . The registered office is London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2022: NIL)
- -
4. Debtors
2023 2022
£ £
Due within one year
Other debtors 57,568 57,568
5. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Accruals and deferred income 40,998 40,998
6. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 1 1
7. Related Party Transactions
The Company acquired a license over certain intellectual property relating to animal healthcare from Tecrea Ltd for a consideration of USD800,000. Tecrea Ltd is related party with common directors.
Page 2